About
Biobot Surgical is a medical robotics company based in Singapore, focused on robotic-assisted solutions for prostate cancer diagnosis and treatment. As the first surgical robotics venture from Singapore’s academic and clinical ecosystem, the company aims to enhance prostate healthcare on a global scale. Biobot Surgical has completed over 25,000 procedures in collaboration with urologists, showcasing its significant clinical impact. The flagship product, the iSR’obot Mona Lisa, is a robotic needle positioning system that allows urologists and radiologists to perform precise prostate biopsies and interventional procedures. This system achieves robotic accuracy within 1.0 mm and integrates advanced imaging fusion of MRI and ultrasound, improving cancer detection rates while minimizing infection risks. Biobot Surgical's solutions support healthcare providers in delivering safer and more accurate prostate cancer diagnostics and treatments, addressing the global burden of prostate cancer affecting over 1.2 million men annually.
Technologies
Keywords
Company Information
-
Employees 41
-
Founded 2007
-
Annual Revenue $4000000
-
Total Funding $26520000
Location
79 Ayer Rajah Cres, Singapore, Singapore, 139955